Endogenous opiates and behavior: 2002

被引:32
作者
Bodnar, RJ
Hadjimarkou, MM
机构
[1] CUNY Queens Coll, Dept Psychol, Flushing, NY 11367 USA
[2] CUNY Queens Coll, Neuropsychol Doctoral Sub Program, Flushing, NY 11367 USA
关键词
endogenous opiates; behavior; opioid peptides;
D O I
10.1016/j.peptides.2003.08.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This paper is the twenty-fifth consecutive installment of the annual review of research concerning the endogenous opioid system, now spanning over a quarter-century of research. It summarizes papers published during 2002 that studied the behavioral effects of molecular, pharmacological and genetic manipulation of opioid peptides, opioid receptors, opioid agonists and opioid antagonists. The particular topics that continue to be covered include the molecular-biochemical effects and neurochemical localization studies of endogenous opioids and their receptors related to behavior (Section 2), and the roles of these opioid peptides and receptors in pain and analgesia (Section 3); stress and social status (Section 4); tolerance and dependence (Section 5); learning and memory (Section 6); eating and drinking (Section 7); alcohol and drugs of abuse (Section 8); sexual activity and hormones, pregnancy, development and endocrinology (Section 9); mental illness and mood (Section 10); seizures and neurologic disorders (Section 11); electrical-related activity and neurophysiology (Section 12); general activity and locomotion (Section 13); gastrointestinal, renal and hepatic functions (Section 14); cardiovascular responses (Section 15); respiration and thermoregulation (Section 16); and immunological responses (Section 17). (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:1241 / 1302
页数:62
相关论文
共 896 条
[61]   Potentiation of morphine analgesia by BQ123, an endothelin antagonist [J].
Bhalla, S ;
Matwyshyn, G ;
Gulati, A .
PEPTIDES, 2002, 23 (10) :1837-1845
[62]   Effects of naloxone benzoylhydrazone on native and recombinant nociceptin/orphanin FQ receptors [J].
Bigoni, R ;
Calò, G ;
Rizzi, A ;
Okawa, H ;
Regoli, D ;
Smart, D ;
Lambert, DG .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2002, 80 (05) :407-412
[63]   Pharmacological characterisation of [(pX)Phe4]nociceptin(1-13)amide analogues -: 1.: In vitro studies [J].
Bigoni, R ;
Rizzi, D ;
Rizzi, A ;
Camarda, V ;
Guerrini, R ;
Lambert, DG ;
Hashiba, E ;
Berger, H ;
Salvadori, S ;
Regoli, D ;
Calo', G .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2002, 365 (06) :442-449
[64]   D-amphetamine-induced behavioral sensitization: Effect of lesioning dopaminergic terminals in the medial prefrontal cortex, the amygdala and the entorhinal cortex [J].
Bjijou, Y ;
De Deurwaerdere, P ;
Spampinato, U ;
Stinus, L ;
Cador, M .
NEUROSCIENCE, 2002, 109 (03) :499-516
[65]   Desensitization of μ-opioid receptor-evoked potassium currents:: Initiation at the receptor, expression at the effector [J].
Blanchet, C ;
Lüscher, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (07) :4674-4679
[66]   The influence of GnRH, oxytocin and vasoactive intestinal peptide on the secretion of β-endorphin and production of cAMP and cGMP by porcine pituitary cells in vitro [J].
Bogacka, I ;
Siawrys, G ;
Okrasa, S ;
Kaminski, T ;
Przala, J .
ANIMAL REPRODUCTION SCIENCE, 2002, 69 (1-2) :125-137
[67]  
Bohn LM, 2002, J NEUROSCI, V22, P10494
[68]   Synergy between μ opioid ligands:: Evidence for functional interactions among μ opioid receptor subtypes [J].
Bolan, EA ;
Tallarida, RJ ;
Pasternak, GW .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 303 (02) :557-562
[69]   Acupuncture beyond the endorphin concept? [J].
Bonta, IL .
MEDICAL HYPOTHESES, 2002, 58 (03) :221-224
[70]   Involvement of activator protein-1 in transcriptional regulation of the human μ-opioid receptor gene [J].
Börner, C ;
Höllt, V ;
Kraus, J .
MOLECULAR PHARMACOLOGY, 2002, 61 (04) :800-805